Immunology

In Other News

• Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

• Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

• Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

• New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder

• New Immune Target Could Support More Precise High Blood Pressure Treatment

• New Cellular Map May Help Predict Crohn’s Disease Course in Children

• Temporal Immune Profiling Reveals How Sepsis States Change Over Time

• Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• Gut “Memory” May Explain Why IBD Flares Return

• AI-Based Antibody Profiling Predicts Strength of COVID-19 Vaccine Response

• Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis

• Immune Cell Blood Test May Predict Melanoma Immunotherapy Response

• Study Reveals Viral Protein Driving COVID-19-Related Vascular Injury

• Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care

• Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

• Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

• Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis

• New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients

• Immune Biomarkers Support Early Risk Stratification in Oral Precancer

• Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis

• Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

• AI Reveals Immune Response Biomarkers Linked to Ebola Survival